News & Articles

The EBV panel can be used to rule out other acute infections, such as missed HIV infections

Rapidly determine affinity, kinetics, and specificity of protein-protein and protein-small molecule interactions and measure protein concentrations in crude samples

Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence

Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges

Dr. Simon Bates’ addition supports continued focus on innovation, development, and customer experience for X-ray analysis

Enhanced insights with unhindered access to high curated quality data combined with advanced visual analytics and data automation

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Next-generation polymer dyes can improve accuracy and brightness with reduced nonspecific staining

Spectrus JS (JavaScript) is the first commercially available browser-based application for processing 1D and 2D NMR data

Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research

Watch this on-demand webinar for expert insight into spectral cell analysis and how it may be used to generate parametric data

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

A response to the unprecedented global demand for key scientific resources

The new system supports remote operability for laboratory processes

Just share a photo of your current incubator to enter the competition

By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days

Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma